https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-acute-heart-failure/ 2024-04-01T03:33:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lung-transplant-rejection/ 2024-04-01T03:32:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bacterial-vaginosis/ 2024-04-01T03:32:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-streptococcal-pneumonia/ 2024-04-01T03:31:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-oropharyngeal-cancer/ 2024-04-01T03:31:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cystic-fibrosis/ 2024-04-01T03:31:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pleural-disease/ 2024-04-01T03:31:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-acute-respiratory-distress-syndrome/ 2024-04-01T03:30:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-obstructive-sleep-apnea/ 2024-04-01T03:30:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cholangitis/ 2024-04-01T03:29:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-eosinophilic-esophagitis/ 2024-04-01T03:30:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-sleep-apnea/ 2024-04-01T03:29:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cluster-headache-syndrome-cluster-headache/ 2024-04-01T03:29:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-partial-seizure/ 2024-04-01T03:28:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-status-epilepticus/ 2024-04-01T03:28:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-atherosclerosis/ 2024-04-01T03:27:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-vasculitis/ 2024-04-01T03:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-influenzavirus-a-infections/ 2024-04-01T03:27:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-coronary-artery-disease-cad-ischemic-heart-disease/ 2024-04-01T03:27:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-varicella-zoster-hhv-3-infections/ 2024-04-01T03:26:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-genital-warts-condylomata-acuminata/ 2024-04-01T03:27:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-peptic-ulcers/ 2024-04-01T03:26:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bone-marrow-transplant-rejection/ 2024-04-01T03:26:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-thromboembolism/ 2024-04-01T03:15:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-duodenal-ulcer/ 2024-04-01T03:25:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-uveitis/ 2024-04-01T03:15:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-respiratory-syncytial-virus-rsv-infections/ 2024-04-01T03:15:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-influenza-a-virus-h1n1-subtype-infections/ 2024-04-01T03:14:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-ocular-hypertension/ 2024-04-01T03:14:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pertussis-whooping-cough/ 2024-04-01T03:14:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-tetanus/ 2024-04-01T03:14:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-myelofibrosis/ 2024-04-01T03:13:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-myasthenia-gravis/ 2024-04-01T03:13:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-gastric-ulcers/ 2024-04-01T03:12:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-glomerulonephritis/ 2024-04-01T03:13:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-alopecia/ 2024-04-01T03:12:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pruritus/ 2024-04-01T03:12:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-narcolepsy/ 2024-04-01T03:11:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-opium-opioid-addiction/ 2024-04-01T03:12:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hypercholesterolemia/ 2024-04-01T03:11:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-attention-deficit-hyperactivity-disorder-adhd/ 2024-04-01T03:11:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-choroidal-neovascularization/ 2024-04-01T03:10:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-macular-edema/ 2024-04-01T03:10:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hypoglycemia/ 2024-04-01T03:10:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cervical-intraepithelial-neoplasia-cin/ 2024-04-01T03:10:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-simplexvirus-hsv-infections/ 2024-04-01T03:09:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-amyloidosis/ 2024-04-01T03:09:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-anca-vasculitis/ 2024-04-01T03:09:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-meningitis/ 2024-04-01T03:09:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lupus-nephritis/ 2024-04-01T03:08:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-primary-biliary-cholangitis-primary-biliary-cirrhosis/ 2024-04-01T03:08:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-reflux-esophagitis-gastroesophageal-reflux-disease/ 2024-04-01T03:07:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hepatic-encephalopathy/ 2024-04-01T03:08:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-peripheral-neuropathy-sensory-neuropathy/ 2024-04-01T03:07:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hidradenitis-suppurativa/ 2024-04-01T03:07:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-vulvar-cancer/ 2024-04-01T03:06:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-neuroblastoma/ 2024-04-01T03:07:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-thyroid-cancer/ 2024-04-01T03:06:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-vaginal-cancer/ 2024-04-01T03:06:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-carcinoid-tumor/ 2024-04-01T03:05:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-salivary-gland-cancer/ 2024-04-01T03:06:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-burkitt-lymphoma/ 2024-04-01T03:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-basal-cell-carcinoma-basal-cell-epithelioma/ 2024-04-01T03:05:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-anal-cancer/ 2024-04-01T03:04:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-malignant-fibrous-histiocytoma/ 2024-04-01T03:04:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-helicobacter-pylori-infections/ 2024-04-01T03:04:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-malaria/ 2024-04-01T03:04:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-diarrhea/ 2024-04-01T03:03:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-axial-spondyloarthritis/ 2024-04-01T03:03:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-radiation-toxicity-radiation-sickness-acute-radiation-syndrome/ 2024-04-01T03:02:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-insomnia/ 2024-04-01T03:03:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cytomegalovirus-hhv-5-infections/ 2024-04-01T03:02:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-poliomyelitis/ 2024-04-01T03:02:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-deep-vein-thrombosis-dvt/ 2024-04-01T03:01:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lyme-disease/ 2024-04-01T03:02:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-rabies/ 2024-04-01T03:01:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-diabetic-nephropathy/ 2024-04-01T03:01:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-herpes-zoster-shingles/ 2024-04-01T03:00:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-tuberculosis/ 2024-04-01T03:01:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-polycythemia-vera/ 2024-04-01T03:00:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-natural-killer-cell-lymphomas/ 2024-04-01T03:00:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-chronic-inflammatory-demyelinating-polyneuropathy-cidp/ 2024-04-01T02:59:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-anemia-in-chronic-kidney-disease-renal-anemia/ 2024-04-01T02:59:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-methicillin-resistant-staphylococcus-aureus-mrsa-infections/ 2024-04-01T02:59:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-dyskinesia/ 2024-04-01T02:59:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bronchitis/ 2024-04-01T02:58:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-post-menopausal-osteoporosis/ 2024-04-01T02:58:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-diabetic-retinopathy/ 2024-04-01T02:58:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-keratoconjunctivitis-sicca-dry-eye/ 2024-04-01T02:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-duchenne-muscular-dystrophy/ 2024-04-01T02:57:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-gastrointestinal-stromal-tumor-gist/ 2024-04-01T02:57:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-dengue-fever/ 2024-04-01T02:56:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-niemann-pick-disease/ 2024-04-01T02:57:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-graft-versus-host-disease-gvhd/ 2024-04-01T02:56:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-kidney-transplant-rejection/ 2024-04-01T02:56:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hereditary-angioedema-hae-c1-esterase-inhibitor-c1-inh-deficiency/ 2024-04-01T02:55:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-primary-immune-deficiency-pid/ 2024-04-01T02:56:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-thrombocytopenia/ 2024-04-01T02:55:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-systemic-sclerosis-scleroderma/ 2024-04-01T02:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-sinusitis/ 2024-04-01T02:54:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hyperoxaluria/ 2024-04-01T02:55:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-chronic-urticaria-or-hives/ 2024-04-01T02:54:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-rhinosinusitis/ 2024-04-01T02:54:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-diabetic-neuropathy/ 2024-04-01T02:53:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-fibromyalgia-fibromyalgia-syndrome/ 2024-04-01T02:53:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-friedreich-ataxia/ 2024-04-01T02:53:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-psychosis/ 2024-04-01T02:53:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-actinic-solar-keratosis/ 2024-04-01T02:52:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hypertriglyceridemia/ 2024-04-01T02:52:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-acne-vulgaris/ 2024-04-01T02:52:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-rosacea/ 2024-04-01T02:52:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-acromegaly/ 2024-04-01T02:51:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-thyroid-gland-disorders/ 2024-04-01T02:51:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-reportedly-eyeing-shockwave-medical-for-takeover/ 2024-03-27T16:49:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-adrenal-gland-disorders/ 2024-04-01T02:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pheochromocytoma/ 2024-04-01T02:51:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hemophilia-b-factor-ix-deficiency/ 2024-04-01T02:50:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-leukocyte-disorders-white-blood-cell-disorders/ 2024-04-01T02:50:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-thalassemia/ 2024-04-01T02:49:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hemophilia-a-factor-viii-deficiency/ 2024-04-01T02:50:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ubiquigent-and-debiopharm-team-up-to-advance-usp1-inhibitor/ 2024-03-27T16:46:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-iron-deficiency-anemia/ 2024-04-01T02:49:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-sickle-cell-disease/ 2024-04-01T02:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pulmonary-embolism/ 2024-04-01T02:48:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-female-sexual-dysfunction/ 2024-04-01T02:49:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-allergic-conjunctivitis/ 2024-04-01T02:48:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-retinal-vein-occlusion/ 2024-04-01T02:48:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-medullary-thyroid-cancer/ 2024-04-01T02:47:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-diabetic-macular-edema/ 2024-04-01T02:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-chronic-myelocytic-leukemia-cml-chronic-myeloid-leukemia/ 2024-04-01T02:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hodgkin-lymphoma-b-cell-hodgkin-lymphoma/ 2024-04-01T02:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-diabetic-gastroparesis/ 2024-04-01T02:46:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-gaucher-disease/ 2024-04-01T02:46:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-polycystic-kidney-disease/ 2024-04-01T02:45:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-onychomycosis-tinea-unguium/ 2024-04-01T02:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lennox-gastaut-syndrome/ 2024-04-01T02:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-chronic-kidney-disease-chronic-renal-failure/ 2024-04-01T02:45:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-glaucoma/ 2024-04-01T02:44:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-familial-hypercholesterolemia-type-ii-hyperlipoproteinemia/ 2024-04-01T02:45:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-irritable-bowel-syndrome/ 2024-04-01T02:44:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hepatitis-c/ 2024-04-01T02:44:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pulmonary-arterial-hypertension/ 2024-04-01T02:43:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-peripheral-arterial-disease-pad-peripheral-vascular-disease-pvd/ 2024-04-01T02:44:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-endometriosis/ 2024-04-01T02:43:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-acute-coronary-syndrome/ 2024-04-01T02:43:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-atrial-fibrillation/ 2024-04-01T02:42:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-dyslipidemia/ 2024-04-01T02:42:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-menopausal-disorders/ 2024-04-01T02:42:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-osteoporosis/ 2024-04-01T02:42:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-allergic-rhinitis/ 2024-04-01T02:41:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-female-contraception/ 2024-04-01T02:41:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/89bio-wins-ema-priority-status-for-mash-candidate-pegozafermin/ 2024-03-27T16:37:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-schizophrenia/ 2024-04-01T02:41:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bipolar-disorder-manic-depression/ 2024-04-01T02:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-angina-angina-pectoris/ 2024-04-01T02:40:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-myocardial-infarction/ 2024-04-01T02:40:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-venous-thromboembolism/ 2024-04-01T02:40:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/juvise-licenses-jjs-ms-drug-ponvory-for-marketing-outside-north-america/ 2024-03-27T15:36:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/oncology-in-2024-the-clinical-trial-trends-reshaping-the-role-of-cros/ 2025-07-14T10:03:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-nipocalimab-fast-track-status/ 2024-03-27T11:03:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-adzynma-japan-approval-cttp/ 2024-03-27T11:12:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avenzo-150m-oncology-pipeline/ 2024-03-27T08:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-merck-winrevair-pnh/ 2024-03-28T16:35:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amneal-gains-fda-greenlight-to-develop-ciprodex-generic-for-ear-infections/ 2024-03-26T17:32:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-hit-with-fda-rejection-for-blood-cancer-therapy/ 2024-03-26T16:35:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-secures-approval-for-gastric-cancer-antibody-in-japan/ 2024-03-26T16:18:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/concerns-drug-compliance-osteoporosis-landscape/ 2024-03-26T15:24:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sosei-group-files-patent-for-novel-compounds-for-treating-disorders-associated-with-apelin-receptors/ 2024-03-26T12:43:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcturus-therapeutics-files-patent-for-modified-human-otc-protein-for-treating-otc-deficiency/ 2024-03-26T12:43:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycomimetics-files-patent-for-treating-cancer-and-related-conditions-with-compound-of-formula-i/ 2024-03-26T12:42:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bicycle-therapeutics-files-patent-for-method-for-determining-cyclisation-extent-of-peptide-ligand/ 2024-03-26T12:42:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genmab-files-patent-for-treatment-of-diffuse-large-b-cell-lymphoma-using-bispecific-antibody/ 2024-03-26T12:42:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sanofi-files-patent-for-method-for-high-level-expression-of-multiple-target-polypeptides/ 2024-03-26T12:42:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pfizer-files-patent-for-multi-drug-antibody-drug-conjugates-with-site-specific-construction/ 2024-03-26T12:41:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nurix-therapeutics-files-patent-for-bifunctional-compounds-for-hpk1-degradation-in-disease-treatment/ 2024-03-26T12:41:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syros-pharmaceuticals-files-patent-for-treating-cancer-with-compound-of-formula-i/ 2024-03-26T12:41:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovent-biologics-files-patent-for-patent-filed-for-novel-heterodimeric-fc-scaffold-proteins/ 2024-03-26T12:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diffusion-pharmaceuticals-files-patent-for-treatment-of-gait-dysfunction-in-neurodegenerative-diseases-using-neflamapimod/ 2024-03-26T12:40:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seres-therapeutics-files-patent-for-bacterial-composition-for-treating-complications-in-immune-suppression/ 2024-03-26T12:40:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/macrogenics-files-patent-for-therapeutic-method-using-modified-polypeptides-for-treating-diseases/ 2024-03-26T12:40:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ipsen-files-patent-for-cancer-therapy-using-ezh2-inhibitor-for-ini1-negative-tumors/ 2024-03-26T12:39:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kobayashi-pharmaceutical-files-patent-for-interdental-cleaning-tool-with-soft-portion-and-dual-dimensions/ 2024-03-26T12:39:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azenta-files-patent-for-substrate-processing-apparatus-with-scara-arm-for-slot-valve-pass-through/ 2024-03-26T12:39:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/therapeutic-solutions-international-files-patent-for-stem-cell-therapy-for-degenerative-conditions/ 2024-03-26T12:39:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/maruho-files-patent-for-emulsion-topical-composition-for-skin-with-benzoyl-peroxide/ 2024-03-26T12:38:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-files-patent-for-process-for-preparing-compound-a/ 2024-03-26T12:38:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hisamitsu-pharmaceutical-files-patent-for-patch-containing-ropinirole-sodium-carboxylate-and-adhesive-agent/ 2024-03-26T12:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biontech-files-patent-for-pharmaceutical-composition-preparation-method-using-lnps-and-mrna/ 2024-03-26T12:38:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/scynexis-files-patent-for-treatment-of-fungal-infections-with-enfumafungin-derivative-triterpenoids/ 2024-03-26T12:37:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunocore-files-patent-for-novel-t-cell-receptors-for-cancer-immunotherapy/ 2024-03-26T12:37:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurinia-pharmaceuticals-files-patent-for-method-to-reduce-nephrotoxicity-in-lupus-nephritis-treatment/ 2024-03-26T12:37:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ac-immune-files-patent-for-novel-compounds-for-treating-diseases-by-modulating-nlrp3-inflammasome-pathway/ 2024-03-26T12:36:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endo-international-files-patent-for-isoproterenol-pharmaceutical-composition-for-intravenous-administration-with-stability-characteristics/ 2024-03-26T12:36:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sutro-biopharma-files-patent-for-antibody-conjugates-targeting-cd74-for-therapy/ 2024-03-26T12:36:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kodiak-sciences-files-patent-for-antibodies-binding-to-complement-factor-d-for-treating-diseases/ 2024-03-26T12:36:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/johnson-johnson-files-patent-for-detection-of-energy-tool-activations-during-surgical-procedures/ 2024-03-26T12:35:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/revance-therapeutics-files-patent-for-treating-migraine-and-sleep-disorders-with-botulinum-toxin/ 2024-03-26T12:35:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mirati-therapeutics-files-patent-for-inhibitors-of-kras-g12d/ 2024-03-26T12:35:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/astellas-pharma-files-patent-for-detection-of-target-cell-type-in-cell-population/ 2024-03-26T12:35:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pharma-mar-files-patent-for-lyophilized-pharmaceutical-composition-of-form-b-of-lurbinectedin/ 2024-03-26T12:34:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corcept-therapeutics-files-patent-for-treatment-of-neuroepithelial-tumors-with-non-steroidal-sgra/ 2024-03-26T12:34:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agenus-files-patent-for-antibodies-binding-to-cd73-for-treating-subjects/ 2024-03-26T12:34:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merus-files-patent-for-inhibiting-biological-activity-of-cells-using-antibodies/ 2024-03-26T12:34:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ionis-pharmaceuticals-files-patent-for-treatment-of-genetic-lipid-disorders-using-isis-678354/ 2024-03-26T12:33:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precision-biosciences-files-patent-for-engineered-meganuclease-for-treating-hepatitis-b-virus-infections/ 2024-03-26T12:33:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kineta-files-patent-for-treating-neurological-disorders-with-pikfyve-inhibitors/ 2024-03-26T12:33:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biomarin-pharmaceutical-files-patent-for-phenylalanine-ammonia-lyase-variants-for-medical-and-industrial-purposes/ 2024-03-26T12:32:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inovio-pharmaceuticals-files-patent-for-method-for-preparing-electroporation-device-for-treatment-using-charge-current/ 2024-03-26T12:32:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ligand-pharmaceuticals-files-patent-for-nucleotide-prodrug-compounds-for-treating-viral-infections/ 2024-03-26T12:32:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eyepoint-pharmaceuticals-files-patent-for-treatment-for-glaucoma-using-tie-2-activator-compound/ 2024-03-26T12:32:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/axsome-therapeutics-files-patent-for-microparticles-containing-bupropion-for-treating-depression/ 2024-03-26T12:31:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/assembly-biosciences-files-patent-for-allosteric-compounds-for-treating-hepatitis-b-virus-infections/ 2024-03-26T12:31:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/santen-pharmaceutical-files-patent-for-pharmaceutical-composition-for-stabilizing-specific-compound-with-preservation-efficacy/ 2024-03-26T12:31:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cipla-files-patent-for-treatment-of-pulmonary-hypertension-using-desipramine-or-its-salt/ 2024-03-26T12:30:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/edgewood-secures-20m-in-series-a-for-clinical-development-of-cancer-therapy/ 2024-03-26T12:43:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-top-emerging-pharmaceutical-companies-in-the-us/ 2024-04-23T11:28:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ingersoll-rand-ilc-buyout/ 2024-03-26T11:02:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nuvation-bio-to-acquire-anheart/ 2024-03-26T11:03:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-alexion-nmosd-ultomiris/ 2024-03-26T09:50:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-acquires-landos-biopharma/ 2024-03-26T09:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-1-1bn-buy-cardior-expand-cardiovascular-pipeline/ 2024-03-25T16:24:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elahere-secures-full-approval-from-fda-for-types-of-ovarian-cancer/ 2024-03-25T15:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/crispr-based-assay-revolutionise-diagnosis-ntm-infections/ 2024-03-25T15:23:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/esperion-snags-us-label-expansion-for-cardiovascular-disease-drugs/ 2024-03-25T12:15:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aribio-licenses-alzheimers-pill-in-china-for-up-to-770m/ 2024-03-25T11:39:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/university-birmingham-lollipop-mouth-cancer/ 2024-03-25T10:58:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-cymabay-therapeutics/ 2024-03-25T10:55:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-jjs-opsynvi/ 2024-03-25T09:38:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-uk-cris-lung-cancer-vaccine/ 2024-03-25T09:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/italfarmaco-secures-fda-approval-for-duchenne-muscular-dystrophy-drug/ 2024-03-22T16:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lisata-clinches-rare-disease-status-for-osteosarcoma-drug/ 2024-03-22T16:14:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innate-shelves-lacutamab-monotherapy-plans-in-peripheral-t-cell-lymphoma/ 2024-03-22T14:17:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chinook-therapeutics-files-patent-for-improving-kidney-function-in-a-subject/ 2024-03-22T12:23:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/verastem-files-patent-for-combination-treatment-of-fak-inhibitor-and-immunotherapy-for-cancer/ 2024-03-22T12:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ascendis-pharma-files-patent-for-ocular-drug-delivery-system-using-cross-linked-ha/ 2024-03-22T12:22:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anges-files-patent-for-crispr-based-method-for-modifying-mutant-lrrk2-gene-in-cells/ 2024-03-22T12:22:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ironwood-pharmaceuticals-files-patent-for-delayed-release-pharmaceutical-composition-containing-linaclotide/ 2024-03-22T12:22:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/purdue-pharma-files-patent-for-purifying-noroxymorphone-by-preparing-and-isolating-bisulfite-adduct/ 2024-03-22T12:21:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biogen-files-patent-for-classification-of-brain-lesions-based-on-single-point-imaging/ 2024-03-22T12:21:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teladoc-health-files-patent-for-personalized-care-program-for-telehealth-platform/ 2024-03-22T12:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cellectis-files-patent-for-engineered-t-cells-for-immunotherapy-with-inhibited-b2m-expression/ 2024-03-22T12:21:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vanda-pharmaceuticals-files-patent-for-treatment-of-psychiatric-disorders-with-r-p88-once-per-day/ 2024-03-22T12:20:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/deciphera-pharmaceuticals-files-patent-for-treatment-of-cancers-by-targeting-tumor-associated-macrophages/ 2024-03-22T12:20:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enzo-biochem-files-patent-for-treatment-of-prostate-cancer-using-ozanimod/ 2024-03-22T12:20:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seagen-files-patent-for-multi-drug-antibody-drug-conjugates-with-site-specific-construction/ 2024-03-22T12:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/coherus-biosciences-files-patent-for-cancer-treatment-method-using-specific-antibodies/ 2024-03-22T12:19:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genexine-files-patent-for-pharmaceutical-composition-for-preventing-or-treating-hpv-caused-diseases/ 2024-03-22T12:19:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/caribou-biosciences-files-patent-for-monoclonal-antibody-for-ror1-cancer-treatment/ 2024-03-22T12:19:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zydus-lifesciences-files-patent-for-liquid-oral-formulation-of-sildenafil-for-various-diseases/ 2024-03-22T12:18:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sarepta-therapeutics-files-patent-for-method-for-expanding-adherent-cells-for-viral-vector-production/ 2024-03-22T12:18:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ono-pharmaceutical-files-patent-for-pharmaceutical-compound-for-disease-prevention-treatment-with-abhd6-inhibitory-activity/ 2024-03-22T12:18:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/csl-files-patent-for-multicistronic-self-replicating-rna-vaccine-with-multiple-antigens/ 2024-03-22T12:18:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/organovo-files-patent-for-farnesoid-x-receptor-agonist-compound-for-treating-diseases/ 2024-03-22T12:17:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/simcere-pharmaceutical-group-files-patent-for-treatment-of-cerebral-stroke-using-composition-of-edaravone-and-dexborneol/ 2024-03-22T12:17:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angelini-files-patent-for-packaging-method-for-plasters-using-thermally-activated-adhesive/ 2024-03-22T12:17:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gc-files-patent-for-purification-method-for-hemopexin-and-haptoglobin/ 2024-03-22T12:17:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-therapeutics-files-patent-for-advanced-manufactured-transwell-with-synthetic-bioink-for-cell-culture/ 2024-03-22T12:16:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xencor-files-patent-for-novel-antibodies-for-treating-gpc3-associated-cancers/ 2024-03-22T12:16:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amicus-therapeutics-files-patent-for-treatment-of-fabry-disease-with-migalastat-for-specific-mutations/ 2024-03-22T12:16:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chong-kun-dang-pharmaceutical-files-patent-for-donepezil-ether-palmitate-hydrochloride-for-sustained-release-pharmaceutical-composition/ 2024-03-22T12:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cspc-pharmaceutical-group-files-patent-for-treatment-method-for-peripheral-t-cell-lymphoma-using-specific-drugs/ 2024-03-22T12:15:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chiesi-farmaceutici-files-patent-for-p2x3-receptor-inhibitors-for-respiratory-diseases/ 2024-03-22T12:15:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sun-pharmaceutical-industries-files-patent-for-hyperparameter-tuning-and-benchmarking-method-for-computational-procedures/ 2024-03-22T12:15:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-files-patent-for-predicting-treatment-outcome-for-neovascular-age-related-macular-degeneration/ 2024-03-22T12:15:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hca-healthcare-files-patent-for-cancer-treatment-micro-beads-with-nano-beads-for-targeted-therapy/ 2024-03-22T12:14:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kissei-pharmaceutical-files-patent-for-reducing-menstrual-blood-loss-using-gnrh-antagonist-compound/ 2024-03-22T12:14:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trevena-files-patent-for-treatment-of-acute-respiratory-distress-syndrome-using-specific-peptides/ 2024-03-22T12:14:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mannkind-files-patent-for-inhalable-pharmaceutical-composition-for-pulmonary-infections-with-clofazimine/ 2024-03-22T12:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zoetis-files-patent-for-improving-canine-antibody-half-life-and-characteristics/ 2024-03-22T12:13:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xenon-pharmaceuticals-files-patent-for-immediate-release-tablet-for-treatment-of-epilepsy/ 2024-03-22T12:13:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intra-cellular-therapies-files-patent-for-pharmaceutical-capsules-containing-lumateperone-for-disease-treatment/ 2024-03-22T12:13:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/moderna-files-patent-for-modified-mrna-for-pharmaceutical-protein-synthesis-with-improved-binding/ 2024-03-22T12:12:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/premier-files-patent-for-secure-medical-dashboard-generation-using-natural-language-processing/ 2024-03-22T12:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grifols-files-patent-for-improving-visual-endpoints-related-to-retina-associated-diseases/ 2024-03-22T12:12:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aileron-therapeutics-files-patent-for-treatment-of-lung-fibrosis-using-modified-cav-1-peptides/ 2024-03-22T12:12:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galderma-files-patent-for-skincare-treatment-compositions-and-methods/ 2024-03-22T12:11:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shionogi-files-patent-for-weight-management-composition-containing-morus-magnolia-and-yerba-mate-extracts/ 2024-03-22T12:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/towa-pharmaceutical-files-patent-for-controlled-release-drug-particles-with-water-insoluble-polymer-coating/ 2024-03-22T12:11:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arrowhead-pharmaceuticals-files-patent-for-rnai-agent-for-inhibiting-sod1-gene-expression/ 2024-03-22T12:11:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/twist-bioscience-files-patent-for-nano-scale-devices-for-manufacturing-high-quality-oligonucleotides/ 2024-03-22T12:10:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hansa-biopharma-files-patent-for-increasing-potency-of-therapeutic-antibodies-for-treating-cancer/ 2024-03-22T12:10:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inhibrx-files-patent-for-multispecific-molecules-that-bind-41bb/ 2024-03-22T12:10:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ars-gears-up-for-neffy-us-approval/ 2024-03-22T14:40:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-hi-bio-felzartamab-odd/ 2024-03-22T11:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lenz-therapeutics-merger-graphite-bio/ 2024-03-22T11:12:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/trend-report-how-the-market-for-prefilled-syringes-is-evolving-in-2024-and-beyond/ 2026-04-07T10:13:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mirador-launch-precision-therapies/ 2024-03-22T09:44:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-novo-nordisk-awiqli/ 2024-03-22T09:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/early-amr-pipeline-looks-beyond-traditional-antibiotics/ 2024-03-21T17:32:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nouscom-extends-series-c-round-to-82m-for-cancer-vaccine-trials/ 2024-03-21T16:27:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/keytruda-combination-treatment-for-nsclc-falls-short-in-phase-iii/ 2024-03-21T16:06:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/molecular-glues-are-the-latest-craze-in-pharma-research-but-what-are-they/ 2024-03-21T16:20:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bionomics-to-advance-non-ssri-ptsd-candidate-to-phase-iii/ 2024-03-21T14:32:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/capstan-car-t-therapy-development/ 2024-03-21T11:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/delivery-and-manufacturing-hurdles-remain-in-the-cell-and-gene-therapy/ 2024-03-21T10:58:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/delivery-tech-remains-challenging-with-gene-therapies-for-brain-disorders/ 2024-03-21T15:07:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-investment-bioprocessing-centre/ 2024-03-21T11:17:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/donanemab-fda-adcom-tau-biomarker-efficacy/ 2024-03-21T14:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-abecma-ec-approval/ 2024-03-21T09:37:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lonza-roche-site/ 2024-03-21T09:39:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/palmoplantar-pustulosis-drugs-in-development/ 2024-09-27T03:50:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/recurrent-respiratory-papillomatosis-juvenile-laryngeal-papilloma-or-laryngeal-papilloma-drugs-in-development/ 2024-09-27T03:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/monkeypox-drugs-in-development/ 2024-09-27T03:43:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beta-thalassaemia-drugs-in-development/ 2024-09-27T03:17:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/choroideremia-drugs-in-development/ 2024-09-27T03:20:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chemotherapy-induced-diarrhea-cid-drugs-in-development/ 2024-09-27T03:20:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chronic-myelomonocytic-leukemia-cmml-drugs-in-development/ 2024-09-27T03:21:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/limbal-stem-cell-deficiency-lscd-drugs-in-development/ 2024-09-27T03:39:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/t-cell-acute-lymphocytic-leukemia-t-cell-acute-lymphoblastic-leukaemia-drugs-in-development/ 2024-09-27T04:03:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/esophageal-squamous-cell-carcinoma-escc-drugs-in-development/ 2024-09-27T03:27:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitochondrial-myopathy-drugs-in-development/ 2024-09-27T03:43:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-drugs-in-development/ 2024-09-27T03:17:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/facioscapulohumeral-muscular-dystrophy-fshd-drugs-in-development/ 2024-09-27T03:27:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/limb-girdle-muscular-dystrophy-drugs-in-development/ 2024-09-27T03:39:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/delayed-graft-function-dgf-drugs-in-development/ 2024-09-27T03:24:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/norovirus-infections-drugs-in-development/ 2024-09-27T03:48:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phelan-mcdermid-syndrome-22q13-3-deletion-syndrome-drugs-in-development/ 2024-09-27T03:52:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iga-nephropathy-berger-s-disease-drugs-in-development/ 2024-09-27T03:36:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angelman-syndrome-drugs-in-development/ 2024-09-27T03:15:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycogen-storage-disease-1a-drugs-in-development/ 2024-03-21T05:40:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pyoderma-gangrenosum-drugs-in-development/ 2024-09-27T03:57:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alopecia-areata-drugs-in-development/ 2024-09-27T03:14:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cavernous-hemangioma-cerebral-cavernous-malformation-cerebral-cavernous-hemangioma-drugs-in-development/ 2024-09-27T03:19:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/panuveitis-drugs-in-development/ 2024-09-27T03:50:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytokine-release-syndrome-cytokine-storm-drugs-in-development/ 2024-09-27T03:23:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/geographic-atrophy-drugs-in-development/ 2024-09-27T03:30:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuroendocrine-gastroenteropancreatic-tumors-gep-net-drugs-in-development/ 2024-09-27T03:46:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corticobasal-degeneration-cbd-cbgd-cortical-basal-ganglionic-degeneration-drugs-in-development/ 2024-03-21T05:38:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/laminin-deficient-congenital-muscular-dystrophy-lama2-md-or-lama2-related-muscular-dystrophy-drugs-in-development/ 2024-03-21T05:37:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinal-vascular-occlusion-drugs-in-development/ 2024-09-27T03:58:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nut-midline-carcinoma-nmc-or-nuclear-protein-in-testis-midline-carcinoma-drugs-in-development/ 2024-09-27T03:48:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adenoid-cystic-carcinoma-acc-drugs-in-development/ 2024-09-27T03:13:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lymphoproliferative-disorders-drugs-in-development/ 2024-09-27T03:40:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-disease-drugs-in-development/ 2024-09-27T03:33:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/splenic-marginal-zone-b-cell-lymphoma-drugs-in-development/ 2024-09-27T04:02:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/post-essential-thrombocythemia-myelofibrosis-post-et-mf-drugs-in-development/ 2024-09-27T03:54:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nodal-marginal-zone-b-cell-lymphoma-drugs-in-development/ 2024-09-27T03:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/extranodal-marginal-zone-b-cell-lymphoma-mucosa-associated-lymphoid-tissue-or-malt-lymphoma-drugs-in-development/ 2024-09-27T03:27:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/craniopharyngioma-drugs-in-development/ 2024-09-27T03:22:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/marginal-zone-b-cell-lymphoma-drugs-in-development/ 2024-09-27T03:41:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avian-influenza-drugs-in-development/ 2024-09-27T03:16:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acute-liver-failure-drugs-in-development/ 2024-09-27T03:12:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/polyomavirus-infections-drugs-in-development/ 2024-09-27T03:53:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rubulavirus-infections-drugs-in-development/ 2024-09-27T04:00:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inherited-skin-disorders-drugs-in-development/ 2024-09-27T03:36:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lymphocryptovirus-infections-drugs-in-development/ 2024-09-27T03:40:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dravet-syndrome-severe-myoclonic-epilepsy-of-infancy-drugs-in-development/ 2024-09-27T03:25:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/epileptic-encephalopathy-drugs-in-development/ 2024-09-27T03:26:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitochondrial-diseases-drugs-in-development/ 2024-09-27T03:43:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prurigo-drugs-in-development/ 2024-09-27T03:56:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cerebral-edema-drugs-in-development/ 2024-09-27T03:19:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endocrine-gland-disorders-drugs-in-development/ 2024-09-27T03:26:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/papillary-renal-cell-carcinoma-drugs-in-development/ 2024-09-27T03:50:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pediatric-diffuse-intrinsic-pontine-glioma-drugs-in-development/ 2024-09-27T03:51:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/low-grade-glioma-drugs-in-development/ 2024-09-27T03:39:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/muscle-spasticity-drugs-in-development/ 2024-09-27T03:44:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cryptococcal-meningitis-drugs-in-development/ 2024-09-27T03:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/venous-vein-thrombosis-drugs-in-development/ 2024-09-27T04:07:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/multifocal-motor-neuropathy-drugs-in-development/ 2024-09-27T03:44:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mammary-ductal-carcinoma-drugs-in-development/ 2024-09-27T03:41:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/propionic-acidemia-drugs-in-development/ 2024-09-27T03:56:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hemorrhagic-cystitis-haemorrhagic-cystitis-drugs-in-development/ 2024-03-21T05:28:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/menkes-disease-kinky-hair-disease-drugs-in-development/ 2024-09-27T03:41:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atopic-keratoconjunctivitis-drugs-in-development/ 2024-09-27T03:16:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stress-urinary-incontinence-drugs-in-development/ 2024-09-27T04:02:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anemia-of-chronic-disease-drugs-in-development/ 2024-03-21T05:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gastrointestinal-tumor-drugs-in-development/ 2024-09-27T03:29:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peripheral-nerve-injury-drugs-in-development/ 2024-09-27T03:52:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hereditary-inclusion-body-myopathy-h-ibm-drugs-in-development/ 2024-03-21T05:26:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fungal-meningitis-drugs-in-development/ 2024-09-27T03:29:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/squamous-non-small-cell-lung-cancer-drugs-in-development/ 2024-09-27T04:02:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/squamous-non-small-cell-lung-carcinoma-drugs-in-development/ 2024-09-27T04:02:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/humoral-hypercalcemia-of-malignancy-drugs-in-development/ 2024-03-21T05:25:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuroendocrine-cancer-drugs-in-development/ 2024-09-27T03:46:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metastatic-uveal-melanoma-drugs-in-development/ 2024-09-27T03:43:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypoxic-ischemic-encephalopathy-drugs-in-development/ 2024-09-27T03:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/familial-chylomicronemia-type-i-hyperlipoproteinemia-drugs-in-development/ 2024-09-27T03:27:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myotonic-dystrophy-drugs-in-development/ 2024-09-27T03:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/androgenic-alopecia-drugs-in-development/ 2024-09-27T03:15:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/familial-amyloid-cardiomyopathy-drugs-in-development/ 2024-09-27T03:27:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leptomeningeal-disease-neoplastic-meningitis-leptomeningeal-carcinomatosis-drugs-in-development/ 2024-09-27T03:39:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chronic-cough-drugs-in-development/ 2024-09-27T03:20:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intracerebral-hemorrhage-drugs-in-development/ 2024-09-27T03:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/polymyalgia-rheumatica-pmr-drugs-in-development/ 2024-09-27T03:53:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/treatment-resistant-depression-drugs-in-development/ 2024-09-27T04:05:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mast-cell-leukemia-drugs-in-development/ 2024-03-21T05:18:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seasonal-influenza-drugs-in-development/ 2024-09-27T04:00:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pandemic-influenza-drugs-in-development/ 2024-09-27T03:50:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/charcot-marie-tooth-disease-type-i-drugs-in-development/ 2024-09-27T03:19:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/primary-hyperoxaluria-type-i-drugs-in-development/ 2024-09-27T03:55:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pollen-allergy-drugs-in-development/ 2024-09-27T03:53:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/primary-progressive-multiple-sclerosis-ppms-drugs-in-development/ 2024-09-27T03:55:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/niemann-pick-disease-type-a-acid-sphingomyelinase-deficiency-drugs-in-development/ 2024-09-27T03:47:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/charcot-marie-tooth-disease-drugs-in-development/ 2024-09-27T03:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/membranoproliferative-glomerulonephritis-type-ii-dense-deposit-disease-drugs-in-development/ 2024-03-21T05:16:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allergic-asthma-drugs-in-development/ 2024-09-27T03:13:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/secondary-progressive-multiple-sclerosis-spms-drugs-in-development/ 2024-09-27T04:00:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hemolytic-uremic-syndrome-drugs-in-development/ 2024-09-27T03:32:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/traveler-s-diarrhea-drugs-in-development/ 2024-09-27T04:05:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/membranoproliferative-glomerulonephritis-mesangiocapillary-glomerulonephritis-drugs-in-development/ 2024-09-27T03:41:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/skin-and-skin-structure-infections-sssi-caused-by-bacteria-drugs-in-development/ 2024-09-27T04:01:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ileus-intestinal-obstruction-drugs-in-development/ 2024-09-27T03:36:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/postoperative-ileus-drugs-in-development/ 2024-03-21T05:14:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/childhood-epilepsy-drugs-in-development/ 2024-09-27T03:20:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seizures-drugs-in-development/ 2024-09-27T04:00:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/urticaria-pigmentosa-mastocytosis-mastocytoma-drugs-in-development/ 2024-03-21T05:13:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peripheral-artery-occlusive-disease-paod-drugs-in-development/ 2024-09-27T03:52:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/memory-impairment-drugs-in-development/ 2024-09-27T03:41:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/relapsing-remitting-multiple-sclerosis-rrms-drugs-in-development/ 2024-09-27T03:58:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/colon-carcinoma-drugs-in-development/ 2024-09-27T03:21:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hormone-sensitive-prostate-cancer-drugs-in-development/ 2024-09-27T03:34:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/occlusive-arterial-disease-oad-drugs-in-development/ 2024-09-27T03:48:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypoxia-drugs-in-development/ 2024-09-27T03:35:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spondyloarthritis-spondyloarthropathy-drugs-in-development/ 2024-09-27T04:02:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hormone-sensitive-breast-cancer-drugs-in-development/ 2024-09-27T03:34:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dedifferentiated-liposarcoma-drugs-in-development/ 2024-09-27T03:23:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/round-cell-liposarcoma-drugs-in-development/ 2024-09-27T03:59:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pleomorphic-liposarcoma-drugs-in-development/ 2024-09-27T03:53:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lung-adenocarcinoma-drugs-in-development/ 2024-09-27T03:39:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metastatic-prostate-cancer-drugs-in-development/ 2024-09-27T03:42:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/malignant-fibrous-histiocytoma-of-soft-tissue-drugs-in-development/ 2024-09-27T03:40:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/colorectal-tumor-drugs-in-development/ 2024-03-21T05:08:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transitional-cell-carcinoma-urothelial-cell-carcinoma-drugs-in-development/ 2024-09-27T04:05:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/papillary-thyroid-cancer-drugs-in-development/ 2024-09-27T03:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thymic-carcinoma-drugs-in-development/ 2024-09-27T04:04:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pancreatic-tumor-drugs-in-development/ 2024-09-27T03:50:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/b-cell-leukemia-drugs-in-development/ 2024-09-27T03:17:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/follicular-thyroid-cancer-drugs-in-development/ 2024-09-27T03:28:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anaplastic-thyroid-cancer-drugs-in-development/ 2024-09-27T03:14:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/plexiform-neurofibroma-drugs-in-development/ 2024-09-27T03:53:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/muscle-invasive-bladder-cancer-mibc-drugs-in-development/ 2024-09-27T03:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/non-muscle-invasive-bladder-cancer-nmibc-superficial-bladder-cancer-drugs-in-development/ 2024-09-27T03:48:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypophosphatasia-drugs-in-development/ 2024-09-27T03:35:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pemphigus-drugs-in-development/ 2024-09-27T03:51:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neurofibroma-drugs-in-development/ 2024-09-27T03:46:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dementia-associated-with-alzheimer-s-disease-drugs-in-development/ 2024-09-27T03:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/severe-combined-immune-deficiency-scid-drugs-in-development/ 2024-09-27T04:01:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/netherton-syndrome-trichorrhexis-invaginata-bamboo-hair-drugs-in-development/ 2024-09-27T03:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acute-lymphoblastic-lymphoma-drugs-in-development/ 2024-09-27T03:12:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angiosarcoma-drugs-in-development/ 2024-09-27T03:15:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/idiopathic-essential-hypertension-drugs-in-development/ 2024-09-27T03:35:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/letterer-siwe-disease-multifocal-and-multisystemic-disseminated-langerhans-cell-histiocytosis-drugs-in-development/ 2024-09-27T03:39:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mucocutaneous-lymph-node-syndrome-kawasaki-disease-drugs-in-development/ 2024-03-21T05:03:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/organic-acidemia-drugs-in-development/ 2024-09-27T03:49:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acute-respiratory-failure-drugs-in-development/ 2024-03-21T05:02:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pesticide-poisoning-drugs-in-development/ 2024-09-27T03:52:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/plaque-psoriasis-psoriasis-vulgaris-drugs-in-development/ 2024-09-27T03:52:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nongerminomatous-nonseminomatous-germ-cell-tumors-drugs-in-development/ 2024-09-27T03:48:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/clear-cell-squamous-cell-carcinoma-drugs-in-development/ 2024-03-21T05:01:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/respiratory-failure-drugs-in-development/ 2024-09-27T03:58:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/primary-cns-lymphoma-drugs-in-development/ 2024-09-27T03:55:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/malignant-glioma-drugs-in-development/ 2024-09-27T03:40:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mesenchymal-tumor-drugs-in-development/ 2024-09-27T03:42:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adrenal-gland-cancer-drugs-in-development/ 2024-09-27T03:13:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/extrahepatic-bile-duct-cancer-drugs-in-development/ 2024-09-27T03:27:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mycosis-fungoides-drugs-in-development/ 2024-09-27T03:44:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/male-contraception-drugs-in-development/ 2024-09-27T03:40:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/juvenile-arthritis-drugs-in-development/ 2024-09-27T03:37:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/systemic-onset-juvenile-idiopathic-arthritis-still-disease-drugs-in-development/ 2024-09-27T04:03:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/systemic-candidiasis-drugs-in-development/ 2024-09-27T04:03:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hemorrhagic-fever-drugs-in-development/ 2024-09-27T03:32:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rift-valley-fever-drugs-in-development/ 2024-09-27T03:59:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/perennial-allergic-rhinitis-drugs-in-development/ 2024-09-27T03:51:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adrenal-insufficiency-drugs-in-development/ 2024-09-27T03:13:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/systemic-aspergillosis-drugs-in-development/ 2024-09-27T04:03:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/human-herpesvirus-8-hhv-8-infections-drugs-in-development/ 2024-03-21T09:56:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neisseria-gonorrhoeae-infections-drugs-in-development/ 2024-09-27T03:45:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/appetite-eating-disorders-drugs-in-development/ 2024-09-27T03:15:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mesenchymal-tumor-of-the-gastrointestinal-tract-drugs-in-development/ 2024-09-27T03:42:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mycobacterium-tuberculosis-infections-drugs-in-development/ 2024-09-27T03:44:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/io360-first-allogeneic-dual-car-t-shows-promise-in-b-cell-non-hodgkin-lymphoma/ 2024-03-20T23:06:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/io360-motixafortide-shows-phase-ii-efficacy-in-first-line-pancreatic-cancer/ 2024-03-20T22:58:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pd-1-inhibitors-and-systemic-oncolytic-viral-immunotherapies-under-the-spotlight-at-io360/ 2024-03-20T21:58:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/are-we-there-yet-the-future-of-cancer-treatment/ 2024-03-20T17:30:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/choriocarcinoma-gestational-trophoblastic-neoplasia-drugs-in-development/ 2024-09-27T03:20:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lewy-body-dementia-drugs-in-development/ 2024-09-27T03:39:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinopathy-drugs-in-development/ 2024-09-27T03:59:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinal-degeneration-drugs-in-development/ 2024-09-27T03:58:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blepharospasm-drugs-in-development/ 2024-03-20T17:16:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/meibomian-blepharitis-drugs-in-development/ 2024-09-27T03:41:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gastroesophageal-ge-junction-carcinomas-drugs-in-development/ 2024-09-27T03:29:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/conjunctivitis-drugs-in-development/ 2024-09-27T03:22:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inherited-mitochondrial-disorders-drugs-in-development/ 2024-09-27T03:36:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inherited-neurodegenerative-diseases-drugs-in-development/ 2024-09-27T03:36:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/congenital-disorder-of-glycosylation-drugs-in-development/ 2024-03-20T17:14:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycogen-storage-disorders-gsd-drugs-in-development/ 2024-09-27T03:30:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/recessive-x-chromosome-disorders-drugs-in-development/ 2024-09-27T03:57:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cystinosis-drugs-in-development/ 2024-09-27T03:23:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seasonal-allergic-rhinitis-drugs-in-development/ 2024-09-27T04:00:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acute-sensorineural-hearing-loss-drugs-in-development/ 2024-09-27T03:12:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tremor-drugs-in-development/ 2024-09-27T04:05:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuropathy-drugs-in-development/ 2024-09-27T03:47:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mucopolysaccharidosis-iv-mps-iv-morquio-syndrome-drugs-in-development/ 2024-09-27T03:43:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leukodystrophies-drugs-in-development/ 2024-09-27T03:39:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vestibular-schwannoma-acoustic-neuroma-drugs-in-development/ 2024-09-27T04:07:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fatty-acid-biosynthesis-disorders-drugs-in-development/ 2024-09-27T03:28:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/malignant-neoplasms-drugs-in-development/ 2024-09-27T03:40:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/subarachnoid-hemorrhage-drugs-in-development/ 2024-09-27T04:03:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chronic-liver-disease-drugs-in-development/ 2024-09-27T03:21:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angioimmunoblastic-t-cell-lymphoma-aitl-immunoblastic-lymphadenopathy-drugs-in-development/ 2024-09-27T03:15:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/food-allergy-drugs-in-development/ 2024-09-27T03:28:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/essential-tremor-drugs-in-development/ 2024-09-27T03:27:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interstitial-lung-diseases-diffuse-parenchymal-lung-disease-drugs-in-development/ 2024-09-27T03:37:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ovarian-disease-drugs-in-development/ 2024-09-27T03:50:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approves-wegovy-for-reducing-risk-of-cardiovascular-death/ 2024-03-20T17:09:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trypanosomiasis-drugs-in-development/ 2024-09-27T04:05:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pulmonary-hypertension-drugs-in-development/ 2024-09-27T03:56:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pneumocystis-pneumonia-pneumocystosis-pneumocystis-jiroveci-pneumonia-drugs-in-development/ 2024-03-20T17:08:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/helminthiasis-parasitic-worm-infestation-drugs-in-development/ 2024-09-27T03:32:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/klebsiella-infections-drugs-in-development/ 2024-09-27T03:38:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dermatomycoses-drugs-in-development/ 2024-09-27T03:24:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thrombophilia-drugs-in-development/ 2024-09-27T04:04:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hemoglobinuria-drugs-in-development/ 2024-09-27T03:32:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/malabsorption-syndrome-drugs-in-development/ 2024-09-27T03:40:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/porphyria-erythropoietic-protoporphyri-drugs-in-development/ 2024-09-27T03:54:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/generalized-anxiety-disorder-gad-drugs-in-development/ 2024-09-27T03:29:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hearing-disorders-drugs-in-development/ 2024-09-27T03:31:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aortic-valve-stenosis-drugs-in-development/ 2024-03-20T17:05:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radiculopathy-drugs-in-development/ 2024-09-27T03:57:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diastolic-heart-failure-hfpef-drugs-in-development/ 2024-09-27T03:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ischemic-cardiomyopathy-drugs-in-development/ 2024-09-27T03:37:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pulmonary-tuberculosis-drugs-in-development/ 2024-09-27T03:57:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/systolic-heart-failure-drugs-in-development/ 2024-09-27T04:03:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/open-angle-glaucoma-drugs-in-development/ 2024-09-27T03:49:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/primary-ciliary-dyskinesia-drugs-in-development/ 2024-09-27T03:55:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neurofibromatoses-drugs-in-development/ 2024-09-27T03:46:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/small-intestine-cancer-drugs-in-development/ 2024-09-27T04:01:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/urea-cycle-disorders-drugs-in-development/ 2024-09-27T04:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lymphoblastic-lymphoma-drugs-in-development/ 2024-09-27T03:40:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lymphedema-drugs-in-development/ 2024-03-20T17:01:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dermatophytosis-drugs-in-development/ 2024-09-27T03:24:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tuberous-sclerosis-drugs-in-development/ 2024-09-27T04:05:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acquired-autoimmune-hemolytic-anemia-drugs-in-development/ 2024-09-27T03:12:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dermatological-disorders-drugs-in-development/ 2024-09-27T03:24:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hepatic-injury-drugs-in-development/ 2024-09-27T03:32:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acute-heart-failure-drugs-in-development/ 2024-09-27T03:12:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuromuscular-disorders-drugs-in-development/ 2024-09-27T03:47:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/haemophilus-influenzae-infections-drugs-in-development/ 2024-09-27T03:31:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/streptococcal-pneumonia-drugs-in-development/ 2024-09-27T04:02:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acute-lung-injury-drugs-in-development/ 2024-09-27T03:12:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allergic-bronchopulmonary-aspergillosis-drugs-in-development/ 2024-09-27T03:13:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/obstructive-sleep-apnea-drugs-in-development/ 2024-09-27T03:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pleural-disease-drugs-in-development/ 2024-09-27T03:53:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proctitis-drugs-in-development/ 2024-09-27T03:56:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neonatal-respiratory-distress-syndrome-drugs-in-development/ 2024-09-27T03:46:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cholangitis-drugs-in-development/ 2024-09-27T03:20:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pancreatic-diseases-drugs-in-development/ 2024-09-27T03:50:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sleep-apnea-drugs-in-development/ 2024-09-27T04:01:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biliary-tumor-drugs-in-development/ 2024-09-27T03:17:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/status-epilepticus-drugs-in-development/ 2024-09-27T04:02:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cerebral-infarction-brain-infarction-drugs-in-development/ 2024-09-27T03:19:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myoclonic-seizure-drugs-in-development/ 2024-09-27T03:45:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/partial-seizure-drugs-in-development/ 2024-09-27T03:51:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thromboangiitis-obliterans-buerger-disease-drugs-in-development/ 2024-09-27T04:04:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lafora-disease-unverricht-disease-drugs-in-development/ 2024-09-27T03:38:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/antiphospholipid-syndrome-drugs-in-development/ 2024-09-27T03:15:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vasculitis-drugs-in-development/ 2024-09-27T04:07:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endocarditis-drugs-in-development/ 2024-03-21T07:56:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heart-valve-disease-drugs-in-development/ 2024-09-27T03:31:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cardiac-arrest-drugs-in-development/ 2024-09-27T03:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endomyocardial-eosinophilic-disease-drugs-in-development/ 2024-09-27T03:26:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genital-warts-condylomata-acuminata-drugs-in-development/ 2024-09-27T03:30:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/influenzavirus-a-infections-drugs-in-development/ 2024-09-27T03:36:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/turner-syndrome-drugs-in-development/ 2024-09-27T04:05:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/duodenal-ulcer-drugs-in-development/ 2024-09-27T03:25:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/idiopathic-short-stature-drugs-in-development/ 2024-09-27T03:35:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/varicella-zoster-hhv-3-infections-drugs-in-development/ 2024-09-27T04:06:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thromboembolic-disease-drugs-in-development/ 2024-09-27T04:04:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/panic-disorders-drugs-in-development/ 2024-09-27T03:50:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dyspepsia-indigestion-drugs-in-development/ 2024-09-27T03:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/t-cell-leukemia-drugs-in-development/ 2024-09-27T04:03:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/primitive-neuroectodermal-tumor-pnet-drugs-in-development/ 2024-09-27T03:55:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myopia-drugs-in-development/ 2024-09-27T03:45:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myelofibrosis-drugs-in-development/ 2024-09-27T03:44:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sarcoidosis-drugs-in-development/ 2024-09-27T04:00:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vitamin-d-deficiency-disorders-drugs-in-development/ 2024-09-27T04:07:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-idorsias-once-daily-antihypertensive-tryvio/ 2024-03-20T16:46:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tauopathies-drugs-in-development/ 2024-09-27T04:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dermatosis-drugs-in-development/ 2024-09-27T03:24:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hemorrhoids-drugs-in-development/ 2024-09-27T03:32:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acostic-neuroma-auditory-nerve-tumor-drugs-in-development/ 2024-09-27T03:12:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aneurysm-drugs-in-development/ 2024-09-27T03:15:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/congenital-heart-disease-drugs-in-development/ 2024-09-27T03:22:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/growth-hormone-deficiency-drugs-in-development/ 2024-09-27T03:31:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-anca-vasculitis-drugs-in-development/ 2024-09-27T03:15:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/simplexvirus-hsv-infections-drugs-in-development/ 2024-09-27T04:01:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peripheral-neuropathy-sensory-neuropathy-drugs-in-development/ 2024-09-27T03:52:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lupus-nephritis-drugs-in-development/ 2024-09-27T03:39:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/congenital-adrenal-hyperplasia-adrenogenital-syndrome-drugs-in-development/ 2024-09-27T03:22:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/testicular-cancer-drugs-in-development/ 2024-09-27T04:04:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thymoma-thymic-epithelial-tumor-drugs-in-development/ 2024-09-27T04:04:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/periodontal-disease-drugs-in-development/ 2024-09-27T03:51:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/germ-cell-tumors-drugs-in-development/ 2024-09-27T03:30:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/penile-cancer-drugs-in-development/ 2024-09-27T03:51:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/salivary-gland-cancer-drugs-in-development/ 2024-09-27T04:00:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/burkitt-lymphoma-drugs-in-development/ 2024-09-27T03:18:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/carcinoid-tumor-drugs-in-development/ 2024-09-27T03:18:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuroendocrine-carcinoma-drugs-in-development/ 2024-09-27T03:46:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/malignant-fibrous-histiocytoma-drugs-in-development/ 2024-09-27T03:40:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chordoma-drugs-in-development/ 2024-09-27T03:20:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metastatic-brain-tumor-drugs-in-development/ 2024-09-27T03:42:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/onchocerciasis-river-blindness-drugs-in-development/ 2024-09-27T03:49:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/helicobacter-pylori-infections-drugs-in-development/ 2024-09-27T03:32:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rickets-drugs-in-development/ 2024-09-27T03:59:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chronic-idiopathic-myelofibrosis-primary-myelofibrosis-drugs-in-development/ 2024-09-27T03:21:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/natural-killer-cell-lymphomas-drugs-in-development/ 2024-09-27T03:45:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lipodystrophy-lipoatrophy-drugs-in-development/ 2024-09-27T03:39:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metastatic-liver-cancer-drugs-in-development/ 2024-09-27T03:42:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metastatic-lung-cancer-drugs-in-development/ 2024-09-27T03:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thrombocytopenia-drugs-in-development/ 2024-09-27T04:04:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/septic-shock-drugs-in-development/ 2024-09-27T04:01:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/niemann-pick-disease-drugs-in-development/ 2024-09-27T03:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nausea-drugs-in-development/ 2024-09-27T03:45:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/focal-segmental-glomerulosclerosis-fsgs-drugs-in-development/ 2024-09-27T03:28:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hyperoxaluria-drugs-in-development/ 2024-09-27T03:34:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/postherpetic-neuralgia-drugs-in-development/ 2024-09-27T03:54:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/psychosis-drugs-in-development/ 2024-09-27T03:56:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rhinosinusitis-drugs-in-development/ 2024-09-27T03:59:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thyroid-gland-disorders-drugs-in-development/ 2024-09-27T04:05:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hyperparathyroidism-drugs-in-development/ 2024-09-27T03:34:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypertriglyceridemia-drugs-in-development/ 2024-09-27T03:35:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emphysema-drugs-in-development/ 2024-09-27T03:25:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leukocyte-disorders-white-blood-cell-disorders-drugs-in-development/ 2024-09-27T03:39:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adrenal-gland-disorders-drugs-in-development/ 2024-09-27T03:13:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/muscle-wasting-disorders-drugs-in-development/ 2024-09-27T03:44:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/edema-drugs-in-development/ 2024-09-27T03:25:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medullary-thyroid-cancer-drugs-in-development/ 2024-09-27T03:41:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anorexia-nervosa-drugs-in-development/ 2024-09-27T03:15:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ascites-drugs-in-development/ 2024-09-27T03:16:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/male-sexual-dysfunction-drugs-in-development/ 2024-03-21T04:34:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acute-coronary-syndrome-drugs-in-development/ 2024-09-27T03:12:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/familial-hypercholesterolemia-type-ii-hyperlipoproteinemia-drugs-in-development/ 2024-09-27T03:27:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lennox-gastaut-syndrome-drugs-in-development/ 2024-09-27T03:38:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bipolar-disorder-manic-depression-drugs-in-development/ 2024-09-27T03:17:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/menopausal-disorders-drugs-in-development/ 2024-09-27T03:41:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/metabolic-syndrome-drugs-in-development/ 2024-09-27T03:42:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/keratoconjunctivitis-drugs-in-development/ 2024-09-27T03:38:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ischemic-stroke-drugs-in-development/ 2024-09-27T03:37:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/venous-thromboembolism-drugs-in-development/ 2024-09-27T04:07:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fdas-marks-says-global-dialogue-on-gene-therapy-regulation-key-for-patient-access/ 2024-04-18T10:10:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/investors-grapple-with-more-choices-in-big-year-for-pharma-fundraising/ 2024-03-20T16:02:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biosecure-act-wuxi-drugs-us-market/ 2024-03-28T09:51:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-biotechs-surf-obesity-drug-wave-to-go-beyond-glp-1ras/ 2024-03-20T13:00:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/croda-aahi-vaccine-adjuvant/ 2024-03-20T10:54:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-hiv-treatment-fda/ 2024-03-20T10:53:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/everest-hsa-approval-nefegan-igan/ 2024-03-20T09:36:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-boehringer-spevigo/ 2024-03-20T09:37:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/is-hiv-tb-coinfection-treatment-entering-a-new-frontier/ 2024-03-18T23:07:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/prevention-over-cure-understanding-the-evolved-care-continuum-and-centralised-data/ 2024-03-19T17:04:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bidens-administration-initiative-aims-to-advance-womens-health-conditions/ 2024-03-19T15:53:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nvidia-doubles-down-on-ai-in-healthcare-with-drug-discovery-deals/ 2024-03-19T15:04:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eli-lilly-partnership-with-amazon-to-boost-presence-in-diabetes-and-obesity-markets/ 2024-03-19T14:55:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asieris-showcases-phase-iii-win-in-treating-precancerous-cervical-lesions/ 2024-03-19T14:32:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-to-acquire-radioconjugate-biotech-fusion-in-2-4bn-deal/ 2024-03-19T13:46:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-kechow-tunlametinib-melanoma/ 2024-03-19T11:35:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/microsoft-nvidia-expand-collaboration/ 2024-03-19T11:31:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-karuna/ 2024-03-19T08:57:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-orchard-lenmeldy-mld/ 2024-03-19T08:52:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/traceability-technologies-tighten-supply-chain-fakery/ 2024-07-02T18:21:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-sandoz-group-humoral-hypercalcemia-of-malignancy-likelihood-of-approval/ 2024-03-18T23:42:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-sandoz-group-giant-cell-tumor-of-bone-likelihood-of-approval/ 2024-04-19T17:28:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-sandoz-group-bone-metastasis-likelihood-of-approval/ 2024-07-05T06:27:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-sandoz-group-post-menopausal-osteoporosis-likelihood-of-approval/ 2024-03-18T23:41:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ulotaront-hydrochloride-sumitomo-pharma-america-generalized-anxiety-disorder-gad-likelihood-of-approval/ 2024-03-18T23:31:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ulotaront-hydrochloride-sumitomo-pharma-america-schizophrenia-likelihood-of-approval/ 2024-04-19T17:06:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cst-2140-curasen-therapeutics-orthostatic-hypotension-likelihood-of-approval/ 2024-03-18T23:29:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adalimumab-biosimilar-biocon-plaque-psoriasis-psoriasis-vulgaris-likelihood-of-approval/ 2024-03-18T17:40:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/defining-hta-landscape-france-germany-20192023/ 2024-03-18T15:57:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/despite-inquiry-fda-adcom-backs-bms-abecma-approval/ 2024-03-18T15:00:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/empowering-clinical-trials-the-technological-revolution-in-patient-retention/ 2024-03-18T15:17:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/norgine-secures-pedmarqsi-licence-from-fennec-in-deal-worth-up-to-272m/ 2024-03-18T14:21:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-expansion-singapore/ 2024-03-18T10:58:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akums-hydroxyurea-suspension/ 2024-03-18T10:56:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-optinose-xhance/ 2024-03-18T08:21:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-johnson-johnson-carvykti/ 2024-03-18T15:15:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-spin-out-pi-health-raises-30m-to-uptick-cancer-trial-enrolment/ 2024-03-15T17:58:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/with-fda-greenlight-bms-breyanzi-brings-car-t-cell-therapy-to-cll-and-sll/ 2024-03-20T14:39:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-committee-back-gerons-blood-disorder-drug/ 2024-03-15T14:04:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-madrigals-rezdiffra-as-the-first-nash-therapy/ 2024-03-15T13:30:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biotheus-hansoh-adc-collaboration/ 2024-03-15T10:46:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anocca-emendobio-gene-editing-technology/ 2024-03-20T14:39:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/noramco-supply-chain-services/ 2024-03-15T08:27:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-beigene-tevimbra/ 2024-03-15T09:33:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/digital-therapeutics-traversing-the-ups-and-downs/ 2024-03-13T20:57:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xcovery-edges-closer-to-fda-approval-for-nsclc-alk-inhibitor/ 2024-03-14T16:25:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-pins-lack-of-long-term-data-as-rationale-for-novartis-failed-vijoice-bid/ 2024-04-10T16:51:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-snaps-up-amolyt-for-1-05bn-to-boost-rare-disease-pipeline/ 2024-03-14T15:09:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-backed-zephyr-ai-secures-111m-for-precision-medicine-tech/ 2024-03-14T14:03:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/almirall-eloxx-zkn-013/ 2024-03-14T10:55:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lgm-pharma-analytical-services/ 2024-03-14T10:53:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-ifm-due/ 2024-03-14T08:28:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-mirum-livmarli/ 2024-03-15T14:42:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/patient-organisations-need-to-tackle-transparency/ 2024-03-13T19:19:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-3427-astrazeneca-net-present-value/ 2024-05-16T01:57:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denecimig-novo-nordisk-net-present-value/ 2024-07-02T02:05:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pn-235-johnson-johnson-net-present-value/ 2024-06-13T18:55:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nipocalimab-johnson-johnson-net-present-value/ 2024-04-16T16:56:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insulin-icodec-semaglutide-novo-nordisk-net-present-value/ 2024-07-02T02:05:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cretostimogene-grenadenorepvec-kissei-pharmaceutical-net-present-value/ 2024-07-02T02:02:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-prevenar-20-expands-eu-label-for-pediatric-streptococcal-pneumonia/ 2024-07-02T18:24:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ukhsa-teams-up-with-pirbright-institute-for-henipavirus-vaccines/ 2024-03-13T15:16:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/galderma-sets-price-range-for-supersized-2-6bn-ipo-in-europe/ 2024-03-13T15:01:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-to-start-trials-investigating-single-dosing-regiments-of-hpv-vaccine/ 2024-03-13T13:31:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allumiqs-prolytix-drug-discovery/ 2024-03-13T11:03:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lamassu-bio-sarcoma-treatment-development/ 2024-03-13T11:01:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/quality-versus-quantity-in-t-cell-production-why-it-doesnt-have-to-be-a-trade-off/ 2024-03-13T14:24:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/automation-risk-management-and-the-manufacture-of-medical-devices/ 2024-03-13T09:26:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bright-green-facility-expansion-us/ 2024-03-13T10:29:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pearl-bio-merck-cancer-therapies/ 2024-03-13T10:23:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jaguar-health-balances-ambitions-for-human-and-animal-pharmaceuticals/ 2024-03-13T21:40:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-seeks-label-expansion-for-tremfya-in-ulcerative-colitis/ 2024-03-12T16:44:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tierra-raises-11-4-in-series-a-round-for-predictive-ai-protein-maker/ 2024-03-12T16:39:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/changing-regulatory-and-analytical-requirements-of-free-amino-acid-monographs-of-the-european-pharmacopoeia/ 2024-03-14T13:42:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/indenas-cdmo-services-full-manufacturing-capabilities-for-pharma-ingredients/ 2024-03-12T14:24:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/terns-scores-fda-orphan-designation-for-cml-therapy/ 2024-03-12T14:21:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/selecta-biosciences-files-patent-for-enhanced-gene-therapy-using-viral-vectors-and-immunosuppressants/ 2024-03-12T13:50:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zealand-pharma-files-patent-for-pharmaceutical-composition-with-glp-1-glp-2-dual-agonist-and-preservatives/ 2024-03-12T13:50:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/astrazeneca-files-patent-for-improved-production-of-aav-vectors-using-specific-plasmid-sequence/ 2024-03-12T13:50:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dr-reddy-s-laboratories-files-patent-for-6-substituted-pyridazine-compounds-for-treating-diseases-dependent-on-smarca2-smarca4/ 2024-03-12T13:49:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbvie-files-patent-for-treatment-of-rheumatoid-arthritis-with-specific-pharmaceutical-composition/ 2024-03-12T13:49:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bristol-myers-squibb-files-patent-for-inhibitors-of-kras-g12d/ 2024-03-12T13:49:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-files-patent-for-method-for-screening-chemical-substances-using-plant-material/ 2024-03-12T13:49:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enanta-pharmaceuticals-files-patent-for-17-hsd13-inhibitors-for-treating-metabolic-disease/ 2024-03-12T13:48:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sangamo-therapeutics-files-patent-for-zinc-finger-fusion-protein-to-treat-neurodegenerative-diseases/ 2024-03-12T13:48:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senju-pharmaceutical-files-patent-for-covid-19-treatment-method-using-specific-compound/ 2024-03-12T13:48:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/daiichi-sankyo-files-patent-for-antibody-drug-conjugate-for-treating-cancer/ 2024-03-12T13:48:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mimedx-group-files-patent-for-tissue-graft-derived-from-placenta-with-exposed-basement-membrane/ 2024-03-12T13:47:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mallinckrodt-files-patent-for-valve-assembly-for-drug-containment-with-radio-frequency-identification/ 2024-03-12T13:47:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sage-therapeutics-files-patent-for-gaba-modulator-pharmaceutical-compositions-for-sedation-and-anesthesia/ 2024-03-12T13:47:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glenmark-pharmaceuticals-files-patent-for-method-for-preparing-virus-inactivated-antibody-solution/ 2024-03-12T13:46:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arbutus-biopharma-files-patent-for-lipid-particles-for-stable-delivery-of-therapeutic-agents/ 2024-03-12T13:46:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/huma-therapeutics-files-patent-for-device-for-predicting-heart-rate-variability-parameter-for-user/ 2024-03-12T13:46:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jazz-pharmaceuticals-files-patent-for-cbd-preparation-for-treating-seizures-associated-with-herpes-simplex-virus/ 2024-03-12T13:46:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bioatla-files-patent-for-method-of-preparing-conditionally-active-polypeptide-from-parent-polypeptide/ 2024-03-12T13:45:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orgenesis-files-patent-for-modified-chimeric-antigen-receptor-car-molecule-with-enhanced-anti-tumor-activity/ 2024-03-12T13:45:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yuhan-files-patent-for-method-for-isolating-nucleic-acid-using-ph-difference-between-buffers/ 2024-03-12T13:45:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/marinus-pharmaceuticals-files-patent-for-injectable-ganaxolone-formulation-for-treating-seizure-disorders/ 2024-03-12T13:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acorda-therapeutics-files-patent-for-dry-powder-lung-surfactant-formulation-for-inhalation-delivery/ 2024-03-12T13:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucb-files-patent-for-antibody-fragment-from-bovine-ultralong-cdr-h3-for-therapy/ 2024-03-12T13:44:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/geron-files-patent-for-method-for-synthesizing-orthogonally-protected-3-amino-nucleoside-monomers/ 2024-03-12T13:44:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocular-therapeutix-files-patent-for-ocular-implant-for-retinal-disease-treatment-with-sustained-release/ 2024-03-12T13:43:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aquestive-therapeutics-files-patent-for-oral-film-for-administering-epinephrine-with-enhanced-permeation-properties/ 2024-03-12T13:43:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/editas-medicine-files-patent-for-genome-editing-system-components-using-engineered-nucleic-acids/ 2024-03-12T13:43:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merck-files-patent-for-animal-management-system-with-virtual-fences-for-monitored-animals/ 2024-03-12T13:43:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phasebio-pharmaceuticals-files-patent-for-sustained-release-pharmaceutical-formulations-for-improved-pharmacokinetics/ 2024-03-12T13:42:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunogen-files-patent-for-combination-therapy-for-hematological-malignancies-using-immunoconjugates/ 2024-03-12T13:42:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shilpa-medicare-files-patent-for-pharmaceutical-composition-in-suspension-form-for-oral-delivery/ 2024-03-12T13:42:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teva-pharmaceutical-industries-files-patent-for-dry-powder-inhalation-formulation-with-fluticasone-and-albuterol/ 2024-03-12T13:42:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/g1-therapeutics-files-patent-for-method-of-treating-triple-negative-breast-cancer-with-cdk4-6-inhibitor/ 2024-03-12T13:41:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-huahai-pharmaceutical-files-patent-for-antigen-binding-protein-binding-to-cd73-with-specific-amino-acid-sequences/ 2024-03-12T13:41:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/a-menarini-industrie-farmaceutiche-riunite-files-patent-for-cancer-treatment-using-epha2-or-il-13ra2-peptide/ 2024-03-12T13:41:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novartis-files-patent-for-combination-therapy-for-b-cell-lymphoma-with-cd19-car-and-bcl2-inhibitor/ 2024-03-12T13:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mersana-therapeutics-files-patent-for-combination-therapy-for-cancer-using-her2-targeted-treatments/ 2024-03-12T13:40:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/puretech-health-files-patent-for-grna-for-modifying-cd7-gene-in-genetically-engineered-cells/ 2024-03-12T13:40:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hanmi-science-files-patent-for-bispecific-antibody-for-pd-l1-and-4-1bb-targeting/ 2024-03-12T13:40:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tiziana-life-sciences-files-patent-for-nasal-delivery-formulation-of-anti-cd3-antibodies/ 2024-03-12T13:39:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bausch-health-files-patent-for-treatment-of-cancer-using-guanylate-cyclase-c-agonist-peptides/ 2024-03-12T13:39:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nektar-therapeutics-files-patent-for-polymer-conjugates-of-tlr-7-8-agonists-for-cancer-treatment/ 2024-03-12T13:39:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpine-immune-sciences-files-patent-for-variant-cd80-fc-fusion-protein-for-immunotherapy/ 2024-03-12T13:38:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eli-lilly-and-co-files-patent-for-novel-compounds-and-methods-for-pretargeted-imaging-formulations/ 2024-03-12T13:16:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iovance-biotherapeutics-files-patent-for-treatment-of-double-refractory-metastatic-melanoma-using-tils/ 2024-03-12T13:16:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-files-patent-for-rsv-f-protein-immunogenic-compositions-and-methods/ 2024-03-12T13:16:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lupin-files-patent-for-ultra-low-dose-drug-delivery-system-for-contraception/ 2024-03-12T13:16:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mei-pharma-files-patent-for-combination-therapy-for-treating-kras-mutant-cancers/ 2024-03-12T13:15:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elanco-animal-health-files-patent-for-antimicrobial-feed-supplement-compositions-for-treating-animal-infections/ 2024-03-12T13:15:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaxcyte-files-patent-for-purification-process-for-bacterial-polysaccharides-for-immunogenic-compositions/ 2024-03-12T13:15:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avidity-biosciences-files-patent-for-treatment-of-muscle-dystrophy-using-polynucleic-acid-molecules/ 2024-03-12T13:15:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cidara-therapeutics-files-patent-for-synthesis-of-conjugates-for-treating-viral-infections/ 2024-03-12T13:14:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wave-life-sciences-files-patent-for-oligonucleotides-for-adenosine-modification-in-treating-diseases/ 2024-03-12T13:14:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crispr-therapeutics-files-patent-for-genome-editing-method-for-treating-amyotrophic-lateral-sclerosis-als/ 2024-03-12T13:14:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/applied-molecular-transport-files-patent-for-oral-delivery-of-therapeutic-payload-using-carrier-payload-complex/ 2024-03-12T13:14:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-crl-mapi-viatris/ 2024-03-12T11:31:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-daiichi-sankyo-quizartinib-aml/ 2024-03-12T11:05:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abcellera-biogen-neurological-antibody-therapy/ 2024-03-12T09:14:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-completes-harpoon-acquisition/ 2024-03-12T09:19:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ad-pd-2024-eli-lillys-donanemab-hit-with-fda-delay/ 2024-03-11T21:59:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ad-pd-2024-biovies-novel-ne3107-shows-promise-but-confirmatory-trial-needed/ 2024-03-11T19:26:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-key-products-you-need-to-trust-your-host-cell-protein-analysis-and-other-process-related-impurity-results/ 2024-04-05T16:05:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-amlitelimab-shows-best-in-class-response-in-atopic-dermatitis/ 2024-03-11T16:18:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-state-of-oligonucleotide-therapeutic-manufacturing-what-biopharmaceutical-players-need-to-know/ 2024-07-01T16:35:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-wins-fda-orphan-drug-status-for-approved-antifungal-cresemba/ 2024-03-11T15:24:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-expands-wegovys-us-label-to-reduce-cardiovascular-events/ 2024-03-11T15:06:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mesoblast-eyes-accelerated-approval-filing-for-heart-failure-cell-therapy/ 2024-03-13T12:57:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eagle-pharmaceuticals-files-patent-for-stable-pemetrexed-formulations-for-cancer-treatment/ 2024-03-11T12:05:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intellia-therapeutics-files-patent-for-genetic-modification-to-reduce-hla-a-protein-expression-in-cells/ 2024-03-11T12:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biora-therapeutics-files-patent-for-ingestible-device-for-delivering-therapeutic-agents/ 2024-03-11T12:04:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/affimed-files-patent-for-trispecific-antibody-construct-for-targeting-immune-effector-and-target-cells/ 2024-03-11T12:04:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/revolution-medicines-files-patent-for-inhibiting-ras-proteins-for-cancer-treatment/ 2024-03-11T12:04:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spruce-biosciences-files-patent-for-treatment-of-congenital-adrenal-hyperplasia-using-crf1-receptor-antagonist/ 2024-03-11T12:04:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/4d-molecular-therapeutics-files-patent-for-gene-therapy-for-fabry-disease-using-optimized-alpha-galactosidase-a-sequence/ 2024-03-11T12:03:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ovid-therapeutics-files-patent-for-cancer-treatment-using-s-3-amino-4-difluoromethylenyl-cyclopent-1-ene-1-carboxylic-acid/ 2024-03-11T12:03:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/codiak-biosciences-files-patent-for-extracellular-vesicles-for-repolarizing-macrophages-in-cancer-treatment/ 2024-03-11T12:03:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/decibel-therapeutics-files-patent-for-cell-lines-expressing-crispr-sam-complex-for-gene-activation/ 2024-03-11T12:03:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lantern-pharma-files-patent-for-synthesizing-illudin-derivatives-for-therapeutic-purposes/ 2024-03-11T12:02:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/homology-medicines-files-patent-for-recombinant-aav-capsid-proteins-for-gene-therapy/ 2024-03-11T12:02:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c4-therapeutics-files-patent-for-degradation-of-neosubstrates-for-treating-various-disorders/ 2024-03-11T12:02:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/owkin-files-patent-for-training-feature-extractor-for-histology-image-analysis/ 2024-03-11T12:01:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tenaya-therapeutics-files-patent-for-treating-metabolic-disease-and-heart-failure-with-hdac6-inhibitor/ 2024-03-11T12:01:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/idorsia-pharmaceutical-files-patent-for-novel-crystalline-forms-of-endothelin-receptor-antagonist/ 2024-03-11T12:01:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vir-biotechnology-files-patent-for-antibodies-for-detecting-treating-and-preventing-metapneumovirus-infection/ 2024-03-11T12:01:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/springworks-therapeutics-files-patent-for-improved-treatment-methods-using-nirogacestat/ 2024-03-11T12:00:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krystal-biotech-files-patent-for-pharmaceutical-composition-for-skin-disorders-with-polynucleotides/ 2024-03-11T12:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ikena-oncology-files-patent-for-mek-inhibitors-for-cancer-treatment/ 2024-03-11T12:00:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bioxcel-therapeutics-files-patent-for-high-dose-dexmedetomidine-for-agitation-in-neurodegenerative-diseases/ 2024-03-25T11:46:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kymera-therapeutics-files-patent-for-compounds-and-methods-for-therapeutic-use/ 2024-03-11T11:59:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beam-therapeutics-files-patent-for-adenosine-base-editors-for-glycogen-storage-disease-type-1a/ 2024-03-11T11:59:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/igm-biosciences-files-patent-for-anti-pd-l1-antibody-for-treating-diseases-mediated-by-pd-l1-signaling/ 2024-03-11T11:59:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-biologics-cayman-files-patent-for-anti-cd39-antibody-for-inhibiting-human-cd39-enzymatic-activity/ 2024-03-11T11:59:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cue-biopharma-files-patent-for-multimeric-antigen-presenting-polypeptide-for-modulating-t-cell-activity/ 2024-03-11T11:58:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bolt-biotherapeutics-files-patent-for-immunoconjugates-for-cancer-treatment-with-anti-pd-l1-antibody/ 2024-03-11T11:58:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-apptec-files-patent-for-process-for-producing-recombinant-aav-particles-with-different-cell-tropisms/ 2024-03-11T11:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/praxis-precision-medicines-files-patent-for-deuterium-enriched-compound-for-treating-t-type-calcium-channel-related-diseases/ 2024-03-11T11:58:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shanghai-junshi-biomedical-technology-files-patent-for-anti-pd-1-antibody-for-treating-nasopharyngeal-carcinoma/ 2024-03-11T11:57:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/foghorn-therapeutics-files-patent-for-compounds-for-treating-baf-complex-related-disorders/ 2024-03-11T11:46:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/i-mab-files-patent-for-cd47-antibody-with-low-immunogenicity-and-rbc-depletion-prevention/ 2024-03-11T11:46:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dyne-therapeutics-files-patent-for-formulation-for-treating-duchenne-muscular-dystrophy/ 2024-03-11T11:45:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sana-biotechnology-files-patent-for-engineered-hypoimmunogenic-cells-for-allogeneic-cell-therapy/ 2024-03-11T11:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/singular-genomics-systems-files-patent-for-image-analysis-method-for-quantifying-features-in-patterns/ 2024-03-11T11:45:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aligos-therapeutics-files-patent-for-pharmaceutical-compound-for-treating-diseases-and-conditions/ 2024-03-11T11:45:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mind-medicine-mindmed-files-patent-for-manufacturing-r-mdma-with-99-enantiomeric-excess/ 2024-03-11T11:44:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/verve-therapeutics-files-patent-for-template-based-gene-editing-using-hybridized-guide-nucleic-acids/ 2024-03-11T11:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grupo-ferrer-internacional-files-patent-for-chemical-heating-unit-with-exothermic-reaction-and-igniter/ 2024-03-11T11:44:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sword-health-files-patent-for-method-for-compensating-drift-between-inertial-sensors-wirelessly/ 2024-03-11T11:44:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kinnate-biopharma-files-patent-for-inhibitors-of-mek-kinase-for-disease-treatment/ 2024-03-11T11:43:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regenxbio-files-patent-for-pharmaceutical-composition-for-treating-eye-diseases-using-aav-vector/ 2024-03-11T11:43:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blueprint-medicines-files-patent-for-treatment-for-diseases-related-to-mutant-kit-and-pdgfra/ 2024-03-11T11:43:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurobindo-pharma-files-patent-for-stable-immediate-release-tablet-of-ubrogepant-with-excipients/ 2024-03-11T11:42:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/les-laboratoires-servier-files-patent-for-combination-pharmaceutical-composition-of-palbociclib-tosylate-and-letrozole/ 2024-03-11T11:42:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medigen-biotechnology-files-patent-for-automated-cell-culture-device-with-clamping-member-for-fluid-control/ 2024-03-11T11:42:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vertex-pharmaceuticals-files-patent-for-cell-housing-device-with-array-of-chemicals-to-increase-surface-area/ 2024-03-11T11:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rigel-pharmaceuticals-files-patent-for-pyrazole-compound-for-inhibiting-irak-protein-in-subjects/ 2024-03-11T11:41:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cumberland-pharmaceuticals-files-patent-for-treatment-of-anthrax-infection-with-telavancin-or-its-salt/ 2024-03-11T11:41:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apellis-pharmaceuticals-files-patent-for-treatment-of-eye-disorders-using-c3-inhibitor/ 2024-03-11T11:41:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-hisun-pharmaceutical-files-patent-for-fgfr4-kinase-inhibitor-for-treating-fgf19-amplification-diseases/ 2024-03-11T11:41:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peptidream-files-patent-for-guanidine-derivative-with-low-cost-and-waste-liquor-prevention/ 2024-03-11T11:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cara-therapeutics-files-patent-for-oral-formulation-for-kappa-opioid-receptor-agonist/ 2024-03-11T11:40:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bluebird-bio-files-patent-for-improved-conditioning-methods-for-hematopoietic-stem-cell-transplantation/ 2024-03-11T11:40:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/e-therapeutics-files-patent-for-nucleic-acid-molecules-for-disease-treatment-or-prevention/ 2024-03-11T11:40:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/almirall-files-patent-for-bispecific-antigen-binding-molecules-targeting-il-13-and-ox40l/ 2024-03-11T11:39:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anaptysbio-files-patent-for-anti-tim-3-antibodies-for-treating-diseases/ 2024-03-11T11:39:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alnylam-pharmaceuticals-files-patent-for-rnai-agents-targeting-complement-factor-b-gene/ 2024-03-11T11:39:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/supernus-pharmaceuticals-files-patent-for-modified-release-formulation-of-viloxazine-with-high-drug-load/ 2024-03-11T11:39:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allakos-files-patent-for-monoclonal-antibody-liquid-formulation-for-subcutaneous-administration/ 2024-03-11T11:38:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/simtra-to-invest-millions-to-expand-its-manufacturing-and-corporate-capabilities/ 2026-04-07T10:24:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-sosei-schizophrenia/ 2024-05-28T11:39:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sun-pharma-recalls-febuxostat-us/ 2024-03-11T10:54:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celltrion-bla-xolair-biosimilar/ 2024-03-11T10:08:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/macau-everest-nda-ulcerative-colitis/ 2024-03-11T09:17:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/whats-next-for-aav-gene-therapies-in-2024/ 2024-03-13T12:57:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ad-pd-2024-taurxs-hmtm-promising-despite-lacking-primary-endpoint-data/ 2024-03-08T19:26:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ad-pd-2024-exploring-cutting-edge-therapies-for-als/ 2024-03-08T18:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-delays-action-on-lillys-donanemab-intent-on-advisory-committee-meeting/ 2024-03-08T16:35:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-secures-accelerated-fda-approval-for-follicular-lymphoma-treatment/ 2024-03-12T17:11:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ad-pd-2024-vaxxinity-reveals-phase-i-success-with-parkinsons-vaccine/ 2024-03-08T15:56:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amylyx-stocks-crash-trial-flop-als-candidate/ 2024-03-08T15:33:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/oligonucleotides-overcoming-sustainability-challenges-with-manufacturing/ 2025-06-27T14:50:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sk-bioscience-vaccine-manufacturing-plant/ 2024-03-08T11:21:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-ambrx/ 2024-03-08T11:22:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-bms-opdivo/ 2024-03-08T09:30:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-marinus-ganaxolone/ 2024-03-08T09:28:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/innovents-ros1-tki-chinese-nsclc-market/ 2024-03-08T07:43:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cts-europe-the-roadmap-for-generative-ai-in-the-pharma-industry/ 2024-03-07T23:20:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/citius-aims-to-bounce-back-from-lymphir-setback/ 2024-03-07T21:10:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sionna-raises-182m-to-double-down-in-cystic-fibrosis-drug-development/ 2024-03-07T16:11:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-net-income-2023/ 2024-03-07T11:06:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-merus-antibody-discovery-deal/ 2024-03-07T10:44:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clinical-trials-in-africa-where-there-is-a-challenge-there-is-an-opportunity/ 2024-03-07T19:40:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-daiichi-sankyo-enhertu/ 2024-03-07T09:23:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alumis-259m-immune-dysfunction-therapies/ 2024-03-07T09:23:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-seeks-eu-approval-for-new-darzalex-multiple-myeloma-indication/ 2024-03-06T16:38:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avacta-group-files-patent-for-extended-circulating-serum-half-life-therapeutic-conjugates/ 2024-03-06T13:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medicinova-files-patent-for-injectable-pharmaceutical-composition-with-sbe-cd-and-ibudilast/ 2024-03-06T13:25:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galapagos-files-patent-for-pharmaceutical-salt-for-treating-inflammatory-autoimmune-and-proliferative-diseases/ 2024-03-06T13:25:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ptc-therapeutics-files-patent-for-pharmaceutical-composition-for-treating-various-diseases/ 2024-03-06T13:24:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amarin-corp-files-patent-for-pharmaceutical-composition-for-treating-carious-diseases-and-disorders/ 2024-03-06T13:24:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precigen-files-patent-for-insect-population-control-using-multiple-lethal-gene-expression-systems/ 2024-03-06T13:24:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kalvista-pharmaceuticals-files-patent-for-treatment-of-bradykinin-mediated-angioedema-with-oral-plasma-kallikrein-inhibitor/ 2024-03-06T13:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rocket-pharmaceuticals-files-patent-for-treatment-method-for-danon-disease-using-raav-virion/ 2024-03-06T13:23:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sorrento-therapeutics-files-patent-for-stable-oral-liquid-pharmaceutical-composition-of-celecoxib-for-pain-relief/ 2024-03-06T13:23:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/navidea-biopharmaceuticals-files-patent-for-polymeric-compound-for-treating-diseases-involving-macrophages/ 2024-03-06T13:23:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elicio-therapeutics-files-patent-for-formulation-of-hgf-sf-mimetic-terevalefim-for-medical-use/ 2024-03-06T13:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ngm-biopharmaceuticals-files-patent-for-binding-agent-for-ilt2-and-ilt4-in-antibodies/ 2024-03-06T13:22:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takeda-pharmaceutical-files-patent-for-antibodies-binding-to-guanylyl-cyclase-c-gcc-for-therapeutic-use/ 2024-03-06T13:22:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jiangsu-hengrui-medicine-files-patent-for-combination-drug-for-preventing-nausea-and-vomiting/ 2024-03-06T13:22:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orexo-files-patent-for-pharmaceutical-composition-for-transmucosal-drug-delivery/ 2024-03-06T13:21:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/valneva-files-patent-for-lipidated-protein-production-method-for-vaccines-against-various-diseases/ 2024-03-06T13:21:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/argenx-files-patent-for-combination-for-treating-myeloid-malignancy-with-cd70-antibody-and-bcl-2-inhibitor/ 2024-03-06T13:21:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/contrafect-files-patent-for-antibacterial-lysin-amp-polypeptide-constructs-and-compositions/ 2024-03-06T13:21:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/actinium-pharmaceuticals-files-patent-for-humanized-anti-human-cd45-antibody-pharmaceutical-compositions/ 2024-03-06T13:20:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zeria-pharmaceutical-files-patent-for-oral-composition-for-treating-inflammatory-bowel-diseases-with-tnfa-antibodies/ 2024-03-06T13:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biogaia-files-patent-for-probiotic-composition-preparation-method-using-gos-for-l-reuteri/ 2024-03-06T13:20:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evotec-files-patent-for-recombinant-expression-vector-for-protein-production-in-mammalian-cells/ 2024-03-06T13:20:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/codexis-files-patent-for-recombinant-neprosin-polypeptide-with-high-sequence-identity/ 2024-03-06T13:19:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/morphosys-files-patent-for-antibodies-for-treating-inflammatory-autoimmune-diseases-or-cancer/ 2024-03-06T13:19:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lonza-group-files-patent-for-cell-culture-chamber-for-automated-cell-engineering-system/ 2024-03-06T13:19:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novavax-files-patent-for-adjuvant-composition-for-enhancing-immune-response/ 2024-03-06T13:19:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fate-therapeutics-files-patent-for-genetically-engineered-ipsc-derived-cells-for-enhanced-therapeutic-effects/ 2024-03-06T13:18:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gilead-sciences-files-patent-for-antibodies-binding-to-hiv-gp120-for-treating-hiv-infection/ 2024-03-06T13:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seelos-therapeutics-files-patent-for-treatment-of-neurodegenerative-diseases-using-viral-vectors-encoding-peptides/ 2024-03-06T13:18:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jubilant-pharmova-files-patent-for-process-for-preparing-highly-concentrated-allergenic-intermediate-from-dilute-extract/ 2024-03-06T13:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexon-files-patent-for-humanized-anti-c1q-antibody-for-therapeutic-use/ 2024-03-06T13:17:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iveric-bio-files-patent-for-treatment-for-idiopathic-polypoidal-choroidal-vasculopathy-using-specific-injections/ 2024-03-06T13:17:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/voyager-therapeutics-files-patent-for-patent-filed-for-viral-vectors-encoding-antibodies-for-disease-treatment/ 2024-03-06T13:17:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agios-pharmaceuticals-files-patent-for-treating-pyruvate-kinase-deficiency-sickle-cell-disease-thalassemia-with-mitapivat/ 2024-03-06T13:16:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radius-health-files-patent-for-treatment-for-reducing-non-vertebral-bone-fractures/ 2024-03-06T13:16:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kura-oncology-files-patent-for-combination-treatment-for-head-and-neck-cancer/ 2024-03-06T13:16:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/recursion-pharmaceuticals-files-patent-for-computer-system-for-identifying-compounds-in-smart-compound-library/ 2024-03-06T13:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pieris-pharmaceuticals-files-patent-for-predicting-positive-cancer-patient-outcomes-with-4-1bb-agonistic-agent/ 2024-03-06T13:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ac-immune-asyn-parkinsons-vaccine-development/ 2024-03-06T15:54:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-growing-uses-of-medicinal-cannabis/ 2025-07-15T12:27:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/why-small-particles-matter-manufacturing-and-micro-material-contamination/ 2024-03-06T10:39:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sonrai-candel-cancer-treatment/ 2024-03-06T10:21:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ono-licence-nex-i-cancer-therapy/ 2024-03-06T09:44:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akari-merger-peak-bio/ 2024-03-06T08:28:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-sandoz-biosimilars/ 2024-03-06T08:32:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-spring-budget-allocates-funds-to-life-sciences-manufacturing/ 2024-03-05T16:24:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-artificial-intelligence-theme-innovation-strategy/ 2024-03-05T12:51:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-in-future-of-work-theme-innovation-strategy/ 2024-08-01T06:12:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azenta-in-future-of-work-theme-innovation-strategy/ 2024-08-01T06:11:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azenta-in-robotics-theme-innovation-strategy/ 2024-08-01T06:11:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-in-digitalization-theme-innovation-strategy/ 2024-03-05T12:50:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-in-robotics-theme-innovation-strategy/ 2024-08-01T06:12:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-in-artificial-intelligence-theme-innovation-strategy-2/ 2024-03-05T12:50:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-in-social-media-theme-innovation-strategy/ 2024-03-05T12:50:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-in-big-data-theme-innovation-strategy/ 2024-03-05T12:49:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-future-of-work-theme-innovation-strategy/ 2024-03-05T12:49:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-artificial-intelligence-theme-innovation-strategy-2/ 2024-03-05T12:49:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/towa-pharmaceutical-gets-grant-for-resin-molding-apparatus-with-metallic-mask-for-substrate-contact/ 2024-03-05T12:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galecto-gets-grant-for-treatment-method-for-galectin-1-binding-disorder-using-galactopyranose-compound/ 2024-03-05T12:41:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/actinium-pharmaceuticals-gets-grant-for-treatment-of-acute-myeloid-leukemia-using-combination-pharmaceutical-therapy/ 2024-03-05T12:41:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/navidea-biopharmaceuticals-gets-grant-for-method-for-conjugating-metal-chelating-agent-to-functionalized-dextran/ 2024-03-05T12:41:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/editas-medicine-gets-grant-for-genome-editing-system-for-detecting-and-measuring-gene-editing-outcomes/ 2024-03-05T12:41:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acadia-pharmaceuticals-gets-grant-for-improved-carbetocin-drug-product-with-increased-resistance-to-aggregation/ 2024-03-05T12:40:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fate-therapeutics-gets-grant-for-method-for-generating-induced-immune-regulatory-cells/ 2024-03-05T12:40:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proqr-therapeutics-gets-grant-for-nucleic-acid-molecule-for-converting-uridine-to-pseudouridine/ 2024-03-05T12:40:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexon-gets-grant-for-treatment-of-various-diseases-using-specific-compounds/ 2024-03-05T12:40:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emcure-pharmaceuticals-gets-grant-for-ready-to-use-carmustine-solution-for-parenteral-administration/ 2024-03-05T12:39:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/reata-pharmaceuticals-gets-grant-for-biaryl-amides-and-coumarin-based-compounds-for-treating-diseases/ 2024-03-05T12:39:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shenzhen-hepalink-pharmaceutical-group-gets-grant-for-pharmaceutical-composition-for-treating-metabolic-diseases-and-liver-disorders/ 2024-03-05T12:39:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/molecular-templates-gets-grant-for-cell-targeting-molecule-with-shiga-toxin-effector-for-therapy/ 2024-03-05T12:39:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/betta-pharmaceuticals-gets-grant-for-bromodomain-inhibitor-in-crystalline-form/ 2024-03-05T12:38:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agios-pharmaceuticals-gets-grant-for-treatment-of-hemolytic-anemia-with-mitapivat-and-cyp3a4-5-inducer/ 2024-03-05T12:38:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocuphire-pharma-gets-grant-for-ophthalmic-solution-for-improving-visual-performance/ 2024-03-05T12:38:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intellia-therapeutics-gets-grant-for-genome-editing-system-for-immunooncology/ 2024-03-05T12:38:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crispr-therapeutics-gets-grant-for-genome-editing-for-treating-glycogen-storage-disease-type-1a/ 2024-03-05T12:37:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beyondspring-gets-grant-for-pharmaceutical-composition-for-treating-cancer/ 2024-03-05T12:37:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/decibel-therapeutics-gets-grant-for-hypertonic-pharmaceutical-composition-for-anti-platinum-chemoprotection/ 2024-03-05T12:37:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eyenovia-gets-grant-for-method-of-delivering-droplets-to-eye-surface/ 2024-03-05T12:37:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eagle-pharmaceuticals-gets-grant-for-long-term-stable-bendamustine-containing-composition-in-sterile-vial/ 2024-03-05T12:36:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pliant-therapeutics-gets-grant-for-treatment-of-fibrotic-diseases-using-compound-of-formula-a/ 2024-03-05T12:36:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kaleido-biosciences-gets-grant-for-glycan-therapeutic-preparation-for-reducing-inflammation-in-gastrointestinal-diseases/ 2024-03-05T12:36:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oric-pharmaceuticals-gets-grant-for-plk4-inhibitors-for-cancer-treatment/ 2024-03-05T12:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/springworks-therapeutics-gets-grant-for-treatment-of-melanoma-using-specific-pharmaceutical-composition/ 2024-03-05T12:35:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tcr2-therapeutics-gets-grant-for-recombinant-nucleic-acid-encoding-tcr-fusion-protein-for-cancer-treatment/ 2024-03-05T12:35:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-apptec-gets-grant-for-process-for-preparing-dichloroacetic-acid-composition-with-low-impurity/ 2024-03-05T12:35:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innocare-pharma-gets-grant-for-trk-inhibitors-for-treating-diseases-such-as-cancers/ 2024-03-05T12:34:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kronos-bio-gets-grant-for-cdk9-inhibitors-for-modulating-kinase-activity-in-patients/ 2024-03-05T12:34:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japanese-patients-among-least-empowered-in-developed-world-study-shows/ 2024-03-05T15:07:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/a2-bio-fda-orphan-drug-status/ 2024-03-06T12:13:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telix-artms-radioisotope-production/ 2024-03-05T10:51:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nocion-funds-cough-treatment/ 2024-03-05T09:46:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-endometrial-cancer-immunotherapy/ 2024-03-05T08:13:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-doubles-down-on-patient-engagement-to-support-rare-disease-research/ 2024-03-04T16:40:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/oncology-dominant-therapy-crispr/ 2024-03-04T15:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-awards-double-validation-for-daiichi-sankyo-and-astrazenecas-cancer-adc/ 2024-03-04T15:41:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-advanced-materials-theme-innovation-strategy/ 2024-03-04T13:16:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-cybersecurity-theme-innovation-strategy-2/ 2024-03-04T13:16:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-digitalization-theme-innovation-strategy/ 2024-03-04T13:16:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-internet-of-things-theme-innovation-strategy/ 2024-03-04T13:15:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-robotics-theme-innovation-strategy/ 2024-03-04T13:15:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-cloud-theme-innovation-strategy/ 2024-03-04T13:15:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-mobile-theme-innovation-strategy/ 2024-03-04T13:14:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-big-data-theme-innovation-strategy/ 2024-03-04T13:14:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-in-big-data-theme-innovation-strategy/ 2024-08-01T06:12:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-in-robotics-theme-innovation-strategy/ 2024-08-01T06:12:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-in-3d-printing-theme-innovation-strategy/ 2024-03-04T13:13:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/memorial-sloan-kettering-cancer-center-in-artificial-intelligence-theme-innovation-strategy-2/ 2024-03-04T13:13:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-in-cybersecurity-theme-innovation-strategy/ 2024-03-04T13:13:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-in-artificial-intelligence-theme-innovation-strategy-2/ 2024-03-04T13:13:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beam-therapeutics-in-advanced-materials-theme-innovation-strategy/ 2024-08-01T06:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biocorrx-files-patent-for-treating-diseases-and-disorders-using-compound-1/ 2024-03-04T13:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amylyx-pharmaceuticals-files-patent-for-treatment-for-neurodegenerative-disease-using-bile-acid-and-phenylbutyrate/ 2024-03-04T13:06:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denali-therapeutics-files-patent-for-solid-forms-of-pharmaceutical-compound-for-medical-use/ 2024-03-04T13:06:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oric-pharmaceuticals-files-patent-for-plk4-inhibitors-for-cancer-treatment/ 2024-03-04T13:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prelude-therapeutics-files-patent-for-bifunctional-compounds-targeting-protein-and-e3-ubiquitin-ligase/ 2024-03-04T13:05:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abcellera-biologics-files-patent-for-creating-mice-with-diverse-heavy-chain-only-antibodies-for-research/ 2024-03-04T13:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nkarta-files-patent-for-genetically-modified-immune-cells-for-safer-immunotherapy-targeting-cd70/ 2024-03-04T13:04:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inozyme-pharma-files-patent-for-treating-allograft-vasculopathy-moyamoya-diseases-inhibiting-intimal-proliferation/ 2024-03-04T13:04:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evelo-biosciences-files-patent-for-pharmaceutical-composition-with-bacteria-spirulina-for-medical-use/ 2024-03-04T13:04:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tonix-pharmaceuticals-holding-files-patent-for-treatment-method-for-fibromyalgia-using-cyclobenzaprine-hcl-eutectic/ 2024-03-04T13:04:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avecho-biotechnology-files-patent-for-oral-cannabinoid-formulation-with-specific-components-and-ratios/ 2024-03-04T13:03:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allogene-therapeutics-files-patent-for-pd-1-chimeric-cytokine-receptor-for-immune-cell-activation/ 2024-03-04T13:03:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-laboratories-international-files-patent-for-oral-preparation-with-jak-inhibitor-for-rapid-dissolution/ 2024-03-04T13:03:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eurofins-scientific-files-patent-for-screening-test-compounds-binding-to-phage-displayed-protein-domain/ 2024-03-04T13:03:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nanobiotix-files-patent-for-porous-high-z-carbon-free-particles-for-oncology-therapy/ 2024-03-04T13:02:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lipocine-files-patent-for-oral-pharmaceutical-composition-for-testosterone-deficiency-treatment/ 2024-03-04T13:02:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/swedish-orphan-biovitrum-files-patent-for-pharmaceutical-formulation-for-treating-elevated-ifn-levels/ 2024-03-04T13:22:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/octapharma-files-patent-for-gene-modification-method-using-crispr-cas-for-cells-with-3-alleles/ 2024-03-04T13:02:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dynavax-technologies-files-patent-for-method-for-determining-cpg-odn-concentration-in-vaccine-formulations/ 2024-03-04T13:01:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/compugen-files-patent-for-screening-method-for-inhibitors-of-pvrig-pvlr2-binding/ 2024-03-04T13:01:31+00:00 daily 0.2